• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

RBC Transfusion Outcomes Similar in ICU Patients with and Without Cardiovascular Disease

January 7, 2026

In intensive care units (ICU), 25%-50% of patients receive RBC transfusions. Up to 30-40% of ICU patients also have a history of cardiovascular disease. Although current transfusion guidelines recommend higher transfusion thresholds for acute cardiac patients, data on RBC transfusions for ICU patients with pre-existing cardiac conditions are limited. Based on observational data from the International Point-Prevalence Study of Intensive-Care Unit Transfusion Practices (InPUT) cohort from 233 centers in 30 countries from six continents, researchers examined clinical outcomes after RBC transfusions in ICU patients with and without a history of cardiovascular disease. Briefly, all adult ICU patients admitted during one week at each center were followed for 28-days or until death or discharge. Of 3,643 ICU patients, 20% had a history of cardiovascular disease and 25% received at least one RBC unit. In patients with and without a history of cardiovascular disease, transfusion rates (25% and 24%), transfusion thresholds (8.5 g/dL and 8.0 g/dL), and the total number of RBC units transfused (both 2 units) were similar, respectively. Based on weighted logistic regression, each additional unit of RBCs increased the odds of death or organ dysfunction (OR, 2.18; 95% C.I., 1.85 to 2.56) regardless of cardiac history. As transfusion threshold data for patients with acute myocardial infarction and preexisting cardiovascular disease have recently changed, it will be important to continue to monitor ICU patients.  A personalized approach to transfusions for patients in the ICU may be beneficial.

Reference:

Kimmoun A, Girerd N, Duarte K, Bruno J, et al; InPUT study Group. Association between red blood cell transfusion and adverse clinical outcomes is Independent of cardiac history: a multicenter observational InPUT study analysis. Crit Care. 2025 Dec 18;29(1):526. doi: 10.1186/s13054-025-05745-5. PMID: 41413913; PMCID: PMC12713240.

Filed Under

  • News
  • RBC Transfusion

Recommended

  • FDA Releases Transfusion-Related Fatalities Report

  • Serological Screening of Blood Donations Suggests SARS-CoV-2 May Have Been Introduced in the US before January 2020

  • Covid-19 Convalescent Plasma Neutralizes Variants of Concern Including Omicron

Show Comments

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • RBC Transfusions to Treat Acute Heavy Menstrual Bleeding

  • RBC Transfusion Outcomes Similar in ICU Patients with and Without Cardiovascular Disease

  • Cryopreserved vs. Standard Platelets for Surgical Bleeding

  • Phosphatidylserine and Phosphatidylethanolamine Levels on RBCs Important for Transfusion Outcomes

    Question of the Day

    Copyright © 2026 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley